Table 1 Patients with anterior uveitis (AU; n = 30): Clinical history and investigations

Age

Mean age (range):

40.7 (19–56)

40.3 (21–69)

Duration

Limited ≤ 3 months

9

14

Persistent > 3 months

6

1

Course

Acute (sudden onset and limited duration)

9

10

Recurrent (repeated episodes separated by periods of inactivity without treatment ≥3 months in duration)

0

5

Chronic (persistent uveitis with relapse in <3 months after discontinuing treatment)

6

0

Treatment duration

<1 week

2

0

1-2 weeks

7

12

3-6 weeks

2

2

7-12 weeks

0

1

Chronic (>12 weeks)

3

0

Long term remission

1

0

HLA-B27

Negative

8

1

Positive

7

14

Relative macular thickening

Normal (235-259 μm females, 244-272 μm males)

5

3

Thickening (≥259 μm females, ≥272 μm males)

9

12

Atrophy (≤238 μm in females, ≤243 μm males)

1

0

Best corrected visual acuity

≥0.8

11

13

0.6-0.7

4

0

0.4-0.5

0

1

0.2-0.3

0

1

AU episode

First episode

7

8

Several episodes

5

7

Chronic

3

0

Anterior chamber cells

Grade 0, <1 cell

4

3

Grade 0.5+, 1–5 cells

1

2

Grade 1+, 6–15 cells

7

5

Grade 2+, 16–25 cells

3

4

Grade 3+, 26–50 cells

0

1

Spillover

No retrolental cells

13

9

1-5 retrolental cells

2

6

Systemic symptoms

Diagnosed spondyloarthropathy

2

9

Joint/ skin/ intestinal/urogenital complaints

4

3

Tiredness, morning stiffness/ pain

6

2

None

3

1

Systemic treatment

None

11

8

Oral prednisolone

2

6

Immunomodulatory treatment

2

1

Uveitis in contralateral eye

Never uveitis in contralateral eye

6

10

At least one earlier episode

7

5

Bilateral uveitis now

2

0

Contralateral AU last three month

Never uveitis

6

10

≤ 3 months prior to examination

1

4

≥ 3 months prior to examination

8

1